JPM

306.32

+0.33%↑

BAC

52.87

+0.32%↑

WFC

87.03

+0.17%↑

MS

165.27

+0.15%↑

AXP

360.18

-0.49%↓

JPM

306.32

+0.33%↑

BAC

52.87

+0.32%↑

WFC

87.03

+0.17%↑

MS

165.27

+0.15%↑

AXP

360.18

-0.49%↓

JPM

306.32

+0.33%↑

BAC

52.87

+0.32%↑

WFC

87.03

+0.17%↑

MS

165.27

+0.15%↑

AXP

360.18

-0.49%↓

JPM

306.32

+0.33%↑

BAC

52.87

+0.32%↑

WFC

87.03

+0.17%↑

MS

165.27

+0.15%↑

AXP

360.18

-0.49%↓

JPM

306.32

+0.33%↑

BAC

52.87

+0.32%↑

WFC

87.03

+0.17%↑

MS

165.27

+0.15%↑

AXP

360.18

-0.49%↓

Search

TPG Specialty Lending Inc

Open

BrancheFinanzen

22.99 -0.04

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

22.57

Max

23.16

Schlüsselkennzahlen

By Trading Economics

Einkommen

22M

59M

Verkäufe

-1.5M

112M

KGV

Branchendurchschnitt

11.388

27.54

Dividendenrendite

9.16

Gewinnspanne

52.464

EBITDA

23M

87M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+5.29% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

9.16%

3.88%

Nächstes Ergebnis

4. Nov. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-97M

2.2B

Vorheriger Eröffnungskurs

23.03

Vorheriger Schlusskurs

22.99

Nachrichtenstimmung

By Acuity

100%

0%

503 / 529 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

TPG Specialty Lending Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

28. Okt. 2025, 23:50 UTC

Heiße Aktien

Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne

28. Okt. 2025, 23:25 UTC

Ergebnisse

SK Hynix Posts Record Earnings on Continued AI-Chip Demand

28. Okt. 2025, 23:18 UTC

Ergebnisse

Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update

28. Okt. 2025, 22:20 UTC

Ergebnisse

Visa Sales Jump as Consumers Keep Spending -- 2nd Update

28. Okt. 2025, 22:13 UTC

Ergebnisse

Wal-Mart de Mexico Net Profit Falls in 3Q

28. Okt. 2025, 21:38 UTC

Ergebnisse

Correction to Visa Sales Jump Article

28. Okt. 2025, 21:17 UTC

Ergebnisse

OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises

28. Okt. 2025, 21:07 UTC

Ergebnisse

Visa Sales Jump as Consumers Keep Spending -- Update

28. Okt. 2025, 21:02 UTC

Ergebnisse

Mondelez Tempers Outlook as Costs Rise

28. Okt. 2025, 23:51 UTC

Market Talk

Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk

28. Okt. 2025, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk

28. Okt. 2025, 23:02 UTC

Ergebnisse

SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026

28. Okt. 2025, 23:01 UTC

Ergebnisse

SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply

28. Okt. 2025, 22:46 UTC

Ergebnisse

SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE

28. Okt. 2025, 22:45 UTC

Ergebnisse

SK Hynix 3Q Net KRW12.6T >000660.SE

28. Okt. 2025, 22:44 UTC

Ergebnisse

SK Hynix 3Q Rev KRW24.44T >000660.SE

28. Okt. 2025, 22:43 UTC

Ergebnisse

SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus

28. Okt. 2025, 22:42 UTC

Ergebnisse

SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE

28. Okt. 2025, 22:40 UTC

Ergebnisse

SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE

28. Okt. 2025, 22:40 UTC

Ergebnisse

SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ

28. Okt. 2025, 22:22 UTC

Ergebnisse

Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ

28. Okt. 2025, 22:20 UTC

Ergebnisse

Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ

28. Okt. 2025, 22:02 UTC

Ergebnisse

Review & Preview: Earnings Extravaganza -- Barrons.com

28. Okt. 2025, 21:42 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

28. Okt. 2025, 21:42 UTC

Market Talk
Ergebnisse

Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk

28. Okt. 2025, 21:20 UTC

Ergebnisse

Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year

28. Okt. 2025, 21:19 UTC

Ergebnisse

Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year

28. Okt. 2025, 21:18 UTC

Ergebnisse

Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year

Peer-Vergleich

Kursveränderung

TPG Specialty Lending Inc Prognose

Kursziel

By TipRanks

5.29% Vorteil

12-Monats-Prognose

Durchschnitt 24.1 USD  5.29%

Hoch 25 USD

Tief 22 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für TPG Specialty Lending Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

8

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

20.83 / 21.65Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über TPG Specialty Lending Inc

Sixth Street Specialty Lending, Inc. (NYSE: TSLX) is a business development company. The fund provides senior secured loans (first-lien, second-lien, and unitranche), unsecured loans, mezzanine debt, and investments in corporate bonds and equity securities and structured products, non-control structured equity, and common equity with a focus on co-investments for organic growth, acquisitions, market or product expansion, restructuring initiatives, recapitalizations, and refinancing. The fund invests in business services, software & technology, healthcare, energy, consumer & retail, manufacturing, industrials, royalty related businesses, education, and specialty finance. It seeks to finance and lending to middle market companies principally located in the United States. The fund invests in companies with enterprise value between $50 million and $1 billion or more and EBITDA between $10 million and $250 million. The transaction size is between $15 million and $350 million. The fund invests across the spectrum of the capital structure and can arrange syndicated transactions of up to $500 million and hold sizeable positions within its credits.
help-icon Live chat